Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.

Hsu EC, Rice MA, Bermudez A, Marques FJG, Aslan M, Liu S, Ghoochani A, Zhang CA, Chen YS, Zlitni A, Kumar S, Nolley R, Habte F, Shen M, Koul K, Peehl DM, Zoubeidi A, Gambhir SS, Kunder CA, Pitteri SJ, Brooks JD, Stoyanova T.

Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 201905384. doi: 10.1073/pnas.1905384117. [Epub ahead of print]

2.

Increasing Clinical Trial Accrual via Automated Matching of Biomarker Criteria.

Chen JW, Kunder CA, Bui N, Zehnder JL, Costa HA, Stehr H.

Pac Symp Biocomput. 2020;25:31-42.

3.

Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology.

Yang SR, Mooney KL, Libiran P, Jones CD, Joshi R, Lau HD, Stehr H, Berry GJ, Zehnder JL, Long SR, Kong CS, Kunder CA.

Cancer Cytopathol. 2020 Jan;128(1):43-56. doi: 10.1002/cncy.22205. Epub 2019 Nov 21.

PMID:
31751001
4.

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients.

Lau HD, Chan E, Fan AC, Kunder CA, Williamson SR, Zhou M, Idrees MT, Maclean FM, Gill AJ, Kao CS.

Am J Surg Pathol. 2020 Jan;44(1):98-110. doi: 10.1097/PAS.0000000000001372.

PMID:
31524643
5.

Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes".

Aredo JV, Padda SK, Kunder CA, Han SS, Neal JW, Shrager JB, Wakelee HA.

Lung Cancer. 2019 Nov;137:159-160. doi: 10.1016/j.lungcan.2019.08.020. Epub 2019 Aug 26. No abstract available.

PMID:
31492438
6.

Molecular profiling of clear cell adenocarcinoma of the urinary tract.

Lin CY, Saleem A, Stehr H, Zehnder JL, Pinsky BA, Kunder CA.

Virchows Arch. 2019 Dec;475(6):727-734. doi: 10.1007/s00428-019-02634-5. Epub 2019 Aug 2.

PMID:
31372739
7.

An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.

Murray CW, Brady JJ, Tsai MK, Li C, Winters IP, Tang R, Andrejka L, Ma RK, Kunder CA, Chu P, Winslow MM.

Cancer Discov. 2019 Nov;9(11):1590-1605. doi: 10.1158/2159-8290.CD-18-1237. Epub 2019 Jul 26.

PMID:
31350327
8.

Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes.

Aredo JV, Padda SK, Kunder CA, Han SS, Neal JW, Shrager JB, Wakelee HA.

Lung Cancer. 2019 Jul;133:144-150. doi: 10.1016/j.lungcan.2019.05.015. Epub 2019 May 15.

PMID:
31200821
9.

Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib.

Wang SXY, Zhang BM, Wakelee HA, Koontz MZ, Pan M, Diehn M, Kunder CA, Neal JW.

Anticancer Drugs. 2019 Jun;30(5):537-541. doi: 10.1097/CAD.0000000000000765.

PMID:
30762593
10.

Structural Variation Detection by Proximity Ligation from Formalin-Fixed, Paraffin-Embedded Tumor Tissue.

Troll CJ, Putnam NH, Hartley PD, Rice B, Blanchette M, Siddiqui S, Ganbat JO, Powers MP, Ramakrishnan R, Kunder CA, Bustamante CD, Zehnder JL, Green RE, Costa HA.

J Mol Diagn. 2019 May;21(3):375-383. doi: 10.1016/j.jmoldx.2018.11.003. Epub 2018 Dec 31.

11.

Performance of multiparametric MRI appears better when measured in patients who undergo radical prostatectomy.

Wang NN, Fan RE, Leppert JT, Ghanouni P, Kunder CA, Brooks JD, Chung BI, Sonn GA.

Res Rep Urol. 2018 Nov 22;10:233-235. doi: 10.2147/RRU.S178064. eCollection 2018.

12.

Adrenal Myelolipomas Involved by Plasma Cell Myeloma.

Lin CY, Levy D, Higgins JPT, Kunder CA, Kao CS.

Am J Clin Pathol. 2018 Oct 1;150(5):406-414. doi: 10.1093/ajcp/aqy068. Review.

PMID:
30052719
13.

Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations.

Wang SXY, Lei L, Guo HH, Shrager J, Kunder CA, Neal JW.

Lung Cancer. 2018 Aug;122:187-191. doi: 10.1016/j.lungcan.2018.06.019. Epub 2018 Jun 15.

PMID:
30032829
14.

ALK-rearranged Tumors Are Highly Enriched in the STUMP Subcategory of Uterine Tumors.

Devereaux KA, Kunder CA, Longacre TA.

Am J Surg Pathol. 2019 Jan;43(1):64-74. doi: 10.1097/PAS.0000000000001083.

PMID:
29794871
15.

Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma.

Yang SR, Lin CY, Stehr H, Long SR, Kong CS, Berry GJ, Zehnder JL, Kunder CA.

J Mol Diagn. 2018 Mar;20(2):184-194. doi: 10.1016/j.jmoldx.2017.10.007. Epub 2017 Dec 19.

16.

KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas.

Kunder CA, Roncador G, Advani RH, Gualco G, Bacchi CE, Sabile JM, Lossos IS, Nie K, Tibshirani RJ, Green MR, Alizadeh AA, Natkunam Y.

Am J Clin Pathol. 2017 Nov 20;148(6):465-476. doi: 10.1093/ajcp/aqx099.

17.

Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.

Gao RW, Berry MF, Kunder CA, Khuong AA, Wakelee H, Neal JW, Backhus LM, Shrager JB.

J Thorac Cardiovasc Surg. 2017 Dec;154(6):2092-2099.e2. doi: 10.1016/j.jtcvs.2017.07.034. Epub 2017 Aug 1.

18.

Development of RET mutant cutaneous angiosarcoma during BRAF inhibitor therapy.

Dai J, Kunder CA, Chu EY, Chan EF, Egan CL, Novoa RA.

J Cutan Pathol. 2017 Dec;44(12):1053-1056. doi: 10.1111/cup.13024. Epub 2017 Sep 13.

PMID:
28796396
19.

Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival.

Berry MF, Gao R, Kunder CA, Backhus L, Khuong A, Kadoch M, Leung A, Shrager J.

Clin Lung Cancer. 2018 Jan;19(1):e47-e51. doi: 10.1016/j.cllc.2017.06.020. Epub 2017 Jul 8.

PMID:
28743420
20.

Mycosis fungoides presenting as symmetric concentric patches mimicking figurate erythema.

Notay M, Petukhova TA, Kiuru M, Kunder CA, Hwang ST.

JAAD Case Rep. 2017 Jun 22;3(4):288-290. doi: 10.1016/j.jdcr.2017.03.013. eCollection 2017 Jul. No abstract available.

21.

Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids.

Banerjee S, Zare RN, Tibshirani RJ, Kunder CA, Nolley R, Fan R, Brooks JD, Sonn GA.

Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3334-3339. doi: 10.1073/pnas.1700677114. Epub 2017 Mar 14.

22.

Indolent thyroid cancer: knowns and unknowns.

Hahn LD, Kunder CA, Chen MM, Orloff LA, Desser TS.

Cancers Head Neck. 2017 Jan 11;2:1. doi: 10.1186/s41199-016-0021-x. eCollection 2017. Review.

23.

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, Maeda LS, Gupta NK, Levy R, Ohgami RS, Kunder CA, Diehn M, Alizadeh AA.

Sci Transl Med. 2016 Nov 9;8(364):364ra155.

24.

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.

Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, Miklos D, Advani RH, Levy R, Hicks RJ, Hertzberg M, Ohgami RS, Gandhi MK, Diehn M, Alizadeh AA.

Blood. 2015 Jun 11;125(24):3679-87. doi: 10.1182/blood-2015-03-635169. Epub 2015 Apr 17.

25.

S1P-Dependent trafficking of intracellular yersinia pestis through lymph nodes establishes Buboes and systemic infection.

St John AL, Ang WXG, Huang MN, Kunder CA, Chan EW, Gunn MD, Abraham SN.

Immunity. 2014 Sep 18;41(3):440-450. doi: 10.1016/j.immuni.2014.07.013.

26.

Mast cell modulation of the vascular and lymphatic endothelium.

Kunder CA, St John AL, Abraham SN.

Blood. 2011 Nov 17;118(20):5383-93. doi: 10.1182/blood-2011-07-358432. Epub 2011 Sep 8. Review.

27.

Mast cell-derived particles deliver peripheral signals to remote lymph nodes.

Kunder CA, St John AL, Li G, Leong KW, Berwin B, Staats HF, Abraham SN.

J Exp Med. 2009 Oct 26;206(11):2455-67. doi: 10.1084/jem.20090805. Epub 2009 Oct 5.

Supplemental Content

Loading ...
Support Center